DIM
OMIC

DLK Investment Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

DLK Investment Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-833
Closed -$12.9K – 119
2024
Q1 		$12.9K Hold
833
– – 0.01% 103
2023
Q4 		$11.5K Buy
+833
New +$9.85K 0.01% 105

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

DLK Investment Management's OMIC Position: Q2 2024 in Review

DLK Investment Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 833 shares — an estimated $12.9K sold.

DLK Investment Management first reported a position in OMIC in Q4 2023 and held it in 2 quarters. The position peaked at $12.9K in Q1 2024. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • DLK Investment Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • DLK Investment Management sold 833 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $12.9K.
  • DLK Investment Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • DLK Investment Management's Singular Genomics Systems, Inc. Common Stock position peaked at $12.9K in Q1 2024.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on DLK Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.